Minoryx is a clinical stage biotech company that researches the development of new therapies for X-ALD, Friedreich's Ataxia and other orphan CNS diseases, a group of rare diseases of genetic origin with a high unmet medical need.
Design and R&D
Vaccines & New biological design
Products, services and capacities
Health & Healthcare Services
Activity classification (NACE)
7211 - Research and experimental development on biotechnology
7490 - Other professional, scientific and technical activities n.e.c.